Immunovant, Inc. IMVT Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s common stock, capital shares reserved for future issuance?
- Immunovant, Inc. (IMVT) reported common stock, capital shares reserved for future issuance of $22.84M in Q4 2025.
- How has Immunovant, Inc.'s common stock, capital shares reserved for future issuance changed year-over-year?
- Immunovant, Inc.'s common stock, capital shares reserved for future issuance decreased by 2.6% year-over-year, from $23.45M to $22.84M.
- What is the long-term trend for Immunovant, Inc.'s common stock, capital shares reserved for future issuance?
- Over 4 years (2021 to 2025), Immunovant, Inc.'s common stock, capital shares reserved for future issuance has grown at a 20.7% compound annual growth rate (CAGR), from $10.88M to $23.04M.